#Term,Database,ID,Input number,Background number,P-Value,Corrected P-Value,Input,Hyperlink,ORF
Endocytosis,n/a,map04144,1,258,0.267146544577132,0.292191533131238,O65719,,O65719
Metabolic pathways,n/a,map01100,15,3837,6.62257514083766E-05,0.00463580259858637,"P0DI10, Q9SHH6, Q9SHH7, Q8GYM1, Q9FLC8, Q39112, Q00917, Q9FHN4, Q94ID1, P32962, Q9SK52, Q9LDN9, Q9SU50, P92983, Q94A08",,P0DI10; Q9SHH6; Q9SHH7; Q8GYM1; Q9FLC8; Q39112; Q00917; Q9FHN4; Q94ID1; P32962; Q9SK52; Q9LDN9; Q9SU50; P92983; Q94A08
Arginine and proline metabolism,n/a,map00330,1,98,0.111948491561729,0.180146997915426,P92983,,P92983
Tryptophan metabolism,n/a,map00380,1,109,0.123591717004543,0.184072770006766,P32962,,P32962
Biosynthesis of secondary metabolites,n/a,map01110,10,2085,0.00023633894428375,0.0023633894428375,"P0DI10, Q9C8J4, Q9FLC8, Q39112, Q00917, Q94ID1, Q9SK52, Q9LDN9, Q9SU50, P92983",,P0DI10; Q9C8J4; Q9FLC8; Q39112; Q00917; Q94ID1; Q9SK52; Q9LDN9; Q9SU50; P92983
Microbial metabolism in diverse environments,n/a,map01120,1,663,0.549841064991927,0.549841064991927,P32962,,P32962
Plant hormone signal transduction,n/a,map04075,1,496,0.44954100494541,0.456056091973605,Q9M7Q5,,Q9M7Q5
Pathogenic Escherichia coli infection,n/a,map05130,1,152,0.167669457415811,0.211474991335258,F4HWY6,,F4HWY6
Phenylpropanoid biosynthesis,n/a,map00940,3,280,0.0049292057150593,0.0230029600036101,"P0DI10, Q9SK52, Q9LDN9",,P0DI10; Q9SK52; Q9LDN9
Starch and sucrose metabolism,n/a,map00500,3,276,0.00473882274283459,0.0236941137141729,"Q9C8J4, Q00917, Q9SU50",,Q9C8J4; Q00917; Q9SU50
Cyanoamino acid metabolism,n/a,map00460,2,104,0.00731151298780457,0.0301062299497835,"Q9FLC8, P32962",,Q9FLC8; P32962
MAPK signaling pathway - plant,n/a,map04016,1,238,0.249327042468168,0.281498273754383,Q9LSF1,,Q9LSF1
Plant-pathogen interaction,n/a,map04626,1,339,0.335119848683284,0.350125215042237,Q9SRE7,,Q9SRE7
Ubiquitin mediated proteolysis,n/a,map04120,1,252,0.261845265719818,0.290939184133131,Q9LTJ6,,Q9LTJ6
RNA degradation,n/a,map03018,1,187,0.201915709895829,0.235568328211801,Q9XF19,,Q9XF19
Legionellosis,n/a,map05134,1,81,0.0936515578272856,0.177178622916486,O65719,,O65719
Longevity regulating pathway - worm,n/a,map04212,3,180,0.00144545090741032,0.00843179695989356,"Q9SHH6, Q9SHH7, Q8GYM1",,Q9SHH6; Q9SHH7; Q8GYM1
Protein processing in endoplasmic reticulum,n/a,map04141,1,364,0.354806157606228,0.365241632829941,O65719,,O65719
PI3K-Akt signaling pathway,n/a,map04151,1,155,0.170661164276601,0.209583885953721,Q8RWC9,,Q8RWC9
AMPK signaling pathway,n/a,map04152,1,141,0.156607877261705,0.210818296313834,Q8RWC9,,Q8RWC9
mRNA surveillance pathway,n/a,map03015,1,196,0.210493318838147,0.241549710142136,Q9C8J1,,Q9C8J1
Peroxisome,n/a,map04146,1,144,0.159639069968294,0.210844054675105,Q9FPH4,,Q9FPH4
Circadian rhythm - plant,n/a,map04712,3,71,0.000102587206855912,0.00359055223995691,"Q39057, Q6LA42, Q9LTJ6",,Q39057; Q6LA42; Q9LTJ6
Autophagy - animal,n/a,map04140,1,145,0.160647061189602,0.208246190430965,Q8RWC9,,Q8RWC9
Nitrogen metabolism,n/a,map00910,1,79,0.0914745121373518,0.18560045940912,P32962,,P32962
Antigen processing and presentation,n/a,map04612,1,78,0.0903840425556969,0.191723726633296,O65719,,O65719
Glucosinolate biosynthesis,n/a,map00966,1,47,0.0559270492949758,0.170212758723839,Q9FLC8,,Q9FLC8
2-Oxocarboxylic acid metabolism,n/a,map01210,1,126,0.141288263061427,0.206045383631248,Q9FLC8,,Q9FLC8
Toxoplasmosis,n/a,map05145,1,81,0.0936515578272856,0.177178622916486,O65719,,O65719
Drug metabolism - other enzymes,n/a,map00983,3,141,0.000725396138728234,0.00507777297109764,"Q9SHH6, Q9SHH7, Q8GYM1",,Q9SHH6; Q9SHH7; Q8GYM1
Zeatin biosynthesis,n/a,map00908,1,59,0.069416381014572,0.17354095253643,Q94ID1,,Q94ID1
Longevity regulating pathway,n/a,map04211,1,65,0.0760890872627758,0.177541203613144,Q8RWC9,,Q8RWC9
Pathways in cancer,n/a,map05200,3,283,0.00507498280393115,0.0222030497671988,"Q9SHH6, Q9SHH7, Q8GYM1",,Q9SHH6; Q9SHH7; Q8GYM1
p53 signaling pathway,n/a,map04115,1,54,0.0638192476173426,0.171821051277461,Q9LTJ6,,Q9LTJ6
FoxO signaling pathway,n/a,map04068,1,90,0.103384324189558,0.17650982178705,Q8RWC9,,Q8RWC9
Measles,n/a,map05162,1,58,0.0682996194782308,0.177073087536154,O65719,,O65719
Hepatocellular carcinoma,n/a,map05225,3,119,0.000447991283419244,0.00348437664881634,"Q9SHH6, Q9SHH7, Q8GYM1",,Q9SHH6; Q9SHH7; Q8GYM1
Thermogenesis,n/a,map04714,1,259,0.268026407436469,0.28864382339312,Q8RWC9,,Q8RWC9
Longevity regulating pathway - multiple species,n/a,map04213,2,73,0.00373532203756777,0.0201132725099803,"O65719, Q8RWC9",,O65719; Q8RWC9
Apelin signaling pathway,n/a,map04371,1,69,0.0805111368081039,0.18179934117959,Q8RWC9,,Q8RWC9
Axon regeneration,n/a,map04361,1,87,0.100151657422401,0.177483949862482,Q8RWC9,,Q8RWC9
Fluid shear stress and atherosclerosis,n/a,map05418,4,197,0.000108622512763424,0.00253452529781322,"Q9SHH6, Q9SHH7, Q8GYM1, Q8RWC9",,Q9SHH6; Q9SHH7; Q8GYM1; Q8RWC9
Insulin signaling pathway,n/a,map04910,1,135,0.150512877946196,0.210718029124674,Q8RWC9,,Q8RWC9
Estrogen signaling pathway,n/a,map04915,1,48,0.0570585387429995,0.159763908480399,O65719,,O65719
Oxytocin signaling pathway,n/a,map04921,1,79,0.0914745121373518,0.18560045940912,Q8RWC9,,Q8RWC9
Glucagon signaling pathway,n/a,map04922,1,133,0.148471506198562,0.212102151712232,Q8RWC9,,Q8RWC9
RNA transport,n/a,map03013,1,285,0.290538203986197,0.30814657998536,Q9C8J1,,Q9C8J1
Glycerophospholipid metabolism,n/a,map00564,1,164,0.179572356795187,0.213051948740053,Q9FLM1,,Q9FLM1
Circadian rhythm,n/a,map04710,1,60,0.0705318131178788,0.170249204077639,Q8RWC9,,Q8RWC9
Tight junction,n/a,map04530,1,98,0.111948491561729,0.180146997915426,Q8RWC9,,Q8RWC9
Basal transcription factors,n/a,map03022,1,87,0.100151657422401,0.177483949862482,Q6PUA2,,Q6PUA2
Pentose and glucuronate interconversions,n/a,map00040,1,152,0.167669457415811,0.211474991335258,Q9FHN4,,Q9FHN4
Galactose metabolism,n/a,map00052,1,96,0.109815096686998,0.183025161144996,Q94A08,,Q94A08
mTOR signaling pathway,n/a,map04150,1,103,0.117259789197583,0.178438809648495,Q8RWC9,,Q8RWC9
Two-component system,n/a,map02020,1,99,0.113013284038133,0.175798441837096,Q9FHN4,,Q9FHN4
Non-alcoholic fatty liver disease (NAFLD),n/a,map04932,1,160,0.175623628075404,0.211959551125488,Q8RWC9,,Q8RWC9
Ribosome biogenesis in eukaryotes,n/a,map03008,1,140,0.155595068642358,0.213561858920884,Q94AH9,,Q94AH9
MAPK signaling pathway,n/a,map04010,1,81,0.0936515578272856,0.177178622916486,O65719,,O65719
Spliceosome,n/a,map03040,2,318,0.056841568068341,0.165787906865995,"Q9C8J1, O65719",,Q9C8J1; O65719
Glutathione metabolism,n/a,map00480,3,172,0.00127193862522133,0.0080941548877721,"Q9SHH6, Q9SHH7, Q8GYM1",,Q9SHH6; Q9SHH7; Q8GYM1
Insulin resistance,n/a,map04931,1,75,0.0871048283730924,0.19054181206614,Q8RWC9,,Q8RWC9
Platinum drug resistance,n/a,map01524,3,115,0.000406433120321865,0.00355628980281632,"Q9SHH6, Q9SHH7, Q8GYM1",,Q9SHH6; Q9SHH7; Q8GYM1
Aminobenzoate degradation,n/a,map00627,1,16,0.0201740724079031,0.0743255299238536,P32962,,P32962
Styrene degradation,n/a,map00643,1,17,0.0213481137182351,0.0747183980138228,P32962,,P32962
Adipocytokine signaling pathway,n/a,map04920,1,36,0.0433913170085157,0.144637723361719,Q8RWC9,,Q8RWC9
Metabolism of xenobiotics by cytochrome P450,n/a,map00980,3,89,0.000195624711263746,0.00273874595769245,"Q9SHH6, Q9SHH7, Q8GYM1",,Q9SHH6; Q9SHH7; Q8GYM1
Drug metabolism - cytochrome P450,n/a,map00982,3,92,0.000215052589678095,0.00250894687957778,"Q9SHH6, Q9SHH7, Q8GYM1",,Q9SHH6; Q9SHH7; Q8GYM1
Diterpenoid biosynthesis,n/a,map00904,1,40,0.0479687776300415,0.152627928822859,Q39112,,Q39112
Chemical carcinogenesis,n/a,map05204,3,84,0.000165840989857554,0.0029022173225072,"Q9SHH6, Q9SHH7, Q8GYM1",,Q9SHH6; Q9SHH7; Q8GYM1
Hypertrophic cardiomyopathy (HCM),n/a,map05410,1,14,0.0178217917867361,0.0693069680595294,Q8RWC9,,Q8RWC9
